Professor of Medical Oncology, University Miami School of Medicine
Oncology
Dr. Mohammad Jahanzeb, MD
|
|
Give Review
Mohammad Jahanzeb works in the field of Oncology. He went to King Edward Medical University. He received awards:"America's Top Doctors", "Gulfstream FL-Broward", "America's Top Doctors for Cancer", "Top Doctors:South Florida", "CMS Meaningful Use Stage 1 Certification", "Gulfstream FL-Palm Beach", "Top Doctors in America", "Award", "Memphis Magazine: Top Doctors", "Best Doctors in America", "Medical Best Doctors in America", "Gold Medal Award Kemcaana", "National Talent Scholarship throughout medical school", "Merit Scholarship throughout high school" and "Super Doctor". Dr. Mohammad Jahanzeb is a published doctor. He published 41 publications, including: 'Results of a trial with topotecan dose escalation and concurrent thoracic radiation therapy for locally advanced, inoperable nonsmall cell lung cancer.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung Can...
- A process for measuring the quality of Cancer care: the Quality Oncology Practice Initiative.
- Non-small cell lung Cancer clinical practice guidelines in oncology.
- HER2 testing in breast Cancer: NCCN Task Force report and recommendations.
- Venous thromboembolic disease. Clinical practice guidelines in oncology.
- Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung Carcinoma (NSCLC): A randomized p...
- Reducing the risk for breast Cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
- American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with Cancer.
- Neoadjuvant chemotherapy in stage III NSCLC.
- NCCN Task Force Report: breast Cancer in the older woman.
- Adjuvant trastuzumab therapy for HER2-positive breast Cancer.
- Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.
- Evolution of bevacizumab-based therapy in the management of breast Cancer.
- Extensive-stage small-cell lung Cancer: evolution of systemic therapy and future directions.
- Breast Cancer. Clinical practice guidelines in oncology.
- Continuing trastuzumab beyond progression.
- Non-small cell lung Cancer.
- Bisphosphonates in lung Cancer: more than a palliative therapy?
- Modification and implementation of NCCN guidelines on non-small cell lung Cancer in the Middle East and North Africa region.
- The Abu Dhabi declaration: why the hustle?
- The process of NCCN guidelines adaptation to the Middle East and North Africa region.
- Modification and implementation of NCCN guidelines on breast Cancer in the Middle East and North Africa region.
- Does race affect outcomes in triple negative breast Cancer?
- Bisphosphonates as antiCancer therapy for early breast Cancer.
- NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders.
- The potential application of zoledronic acid as antiCancer therapy in patients with non-small-cell lung Cancer.
- Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast Cancer.
- Trastuzumab-based combinations in metastatic breast Cancer: how to make a choice.
- Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung Carcinoma: a phase II study.
- Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
- Blockade of the HER Family of Receptors in the Treatment of HER2-Positive Metastatic Breast Cancer.
- Malignant pleural mesothelioma. Clinical practice guidelines in oncology.
- HER-2/neu expression in archival non-small cell lung Carcinomas using FDA-approved Hercep test.
- Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung Cancer.
- Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung Cancer: a preliminary report.
- Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast Cancer.
- Results of a trial with topotecan dose escalation and concurrent thoracic radiation therapy for locally advanced, inoperable nonsmall cell lung Cancer.
- Cancer gene discovery using digital differential display.
- The benefits of support group participation to lung Cancer survivors--an evaluation.
- Evaluation of outcome by race in early-stage non-small cell lung Cancer.
Schools
King Edward Medical College
New Britain Genl Hospital
Wash University
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Gulfstream FL-Broward
- America's Top Doctors for Cancer
- Top Doctors:South Florida
- CMS Meaningful Use Stage 1 Certification
- Gulfstream FL-Palm Beach
- Top Doctors in America
- Award
- Memphis Magazine: Top Doctors
- Best Doctors in America
- Medical Best Doctors in America
- Gold Medal Award Kemcaana
- National Talent Scholarship throughout medical school
- Merit Scholarship throughout high school
- Super Doctor
Education
-
Washington University - Barnes-Jewish Hospital -
King Edward Medical University
Hospital
-
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1114919503 | |
| NPPES Provider LastName | JAHANZEB | |
| NPPES Provider FirstName | MOHAMMAD | |
| NPPES Provider ZIPCode | 334427753 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 414.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 48.0 | |
| Percent Opioid Claims | 11.59 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114919503 |
| Last Name Of The Provider | JAHANZEB |
| First Name Of The Provider | MOHAMMAD |
| View All |
Similar Doctors
|
Dr. James Hoffman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Adriana M. Milillo-Naraine, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Muaiad Kittaneh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pearl H. Seo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Fernando I. De Zarraga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frances Valdes-Albini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan B. Leslie, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lisa D. Reale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Niramol Savaraj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Harrington Jr., MD |
|
|
Dr. Carlos M. Guida, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gustavo L. Fernandez-Castro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter J. Hosein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rakesh Singal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vy T. Dinh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jolly Varki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juan P. Alderuccio, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lionel Noy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean R. Dauphin, DO |
|
|
Dr. Donald S. Ernst, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sabrina E. Martyr, MD
This Doctor is OpenDoctor Recommended.
|